2024-519567-18-00招募中4 期
Bioequivalence of One Tablet of Gliclazide MR 90 mg (S005190) and One and a Half Tablets of Gliclazide MR 60 mg (Diamicron® MR) in Healthy Participants under Fed Conditions.
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 36
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Studies Department
Scientific
Institut De Recherches Internationales Servier IRIS
研究点 (1)
Loading locations...
相似试验
招募中
4 期
Bioequivalence of One Tablet of Gliclazide MR 120 mg (S005190) and Two Tablets of Gliclazide MR 60 mg (Diamicron® MR) in Healthy Participants under Fed Conditions.2024-519250-37-00Institut De Recherches Internationales Servier IRIS36
招募中
Unknown
Bioequivalence study of Gliclazide 80 mg mgIRCT20220111053692N16Tehran Chemie Pharmaceutical Company24
已完成
Unknown
Bioequivalence study of Gliclazide 30 mg Extended Release Tablet (Darou Darman Ariya Sepahan) versus Diamicron MR (SERVIER) Tablet after single oral dosing in healthy volunteersBioequivalence study of Gliclazide 30 mg Extended Release Tablet (Darou Darman Ariya Sepahan) versus Diamicron MR (SERVIER) Tablet after single oral dosing in healthy volunteers.IRCT20220111053692N9Aria Sepahan Pharmaceutical Co24
已完成
Unknown
Bioequivalence study of Gliclazide 30 mg Extended Release Tablet (Tehran Chemie) versus Diamicron MR (SERVIER) Tablet after single oral dosing in healthy volunteersBioequivalence study of Gliclazide 30 mg Extended Release Tablet (Tehran Chemie) versus Diamicron MR (SERVIER) Tablet after single oral dosing in healthy volunteers.IRCT20220111053692N10Tehran Chemie Pharmaceutical Company24
尚未招募
不适用
Bioequivalence study of Gliclazide 60 mg Extended Release Tablet (Tehran Chemie) versus Diamicron MR (SERVIER) Tablet after single oral dosing in healthy volunteersIRCT20220111053692N7Tehran Chemie Pharmaceutical Company24